Our hypothesis was confirmed as FASN loss-of-function experiments mimicked the effect of miRNAs-449 overexpression on cell proliferation and TZ resistance, thus suggesting that miRNA-449 might regulate TZ response through FASN-mediated pathways in HER2 + BC. The gene discussed is FASN; the disease is breast cancer.